ResearcherIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaNo recent work listed
Giovanni Tallini
Matched on ORCID iD 0000-0003-0113-6682; OpenAlex author ID A5085931728. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 4
- Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel. Co-author DOI 10.3390/diagnostics12051058↗
- Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. Co-author DOI 10.1007/s11033-020-05763-2↗
- Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Co-author DOI 10.3233/cbm-170464↗
- Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of divergent populations of tumor cells. Last author DOI 10.1177/1066896912475073↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dario de Biase · 4 shared papers, 2013–2022 · strength 0.31
- Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
- Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
- Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
- Sirio Fiorino · 3 shared papers, 2018–2022 · strength 0.28
- Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
- Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
- Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
- Elio Jovine · 3 shared papers, 2018–2022 · strength 0.28
- Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
- Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
- Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
- Michele Masetti · 3 shared papers, 2018–2022 · strength 0.28
- Paper Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multi… DOI 10.3390/diagnostics12051058↗
- Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
- Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
- Michela Visani · 3 shared papers, 2013–2020 · strength 0.19
- Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
- Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
- Paper Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of… DOI 10.1177/1066896912475073↗
- Carlo Fabbri · 3 shared papers, 2013–2020 · strength 0.19
- Paper Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study. DOI 10.1007/s11033-020-05763-2↗
- Paper Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. DOI 10.3233/cbm-170464↗
- Paper Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of… DOI 10.1177/1066896912475073↗
- Deborah Malvi · 1 shared paper, 2022 · strength 0.12
- Mariacristina Di Marco · 1 shared paper, 2022 · strength 0.12
- Nicola Zanini · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.